A Study of Lazertinib (JNJ-73841937) in Healthy Participants
Status:
Recruiting
Trial end date:
2021-12-30
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effect of steady-state concentrations of
lazertinib on the single-dose pharmacokinetics (PK) of probe substrates (midazolam,
rosuvastatin, and metformin) in healthy adult participants.